ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), the medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization, announced today that it is scheduled to present at the Goldman Sachs Small Cap Healthcare 1x1 Day. The event will be held on Thursday, August 2, 2007 in Chicago. The presentation will not be webcast, however, the slides used for this event will be available beginning August 2, 2007 on the “Investors” section of BioSphere Medical’s website at : www.biospheremed.com.
